Detalhe da pesquisa
1.
An evaluation of the impact of missing deaths on overall survival analyses of advanced non-small cell lung cancer patients conducted in an electronic health records database.
Pharmacoepidemiol Drug Saf
; 28(5): 572-581, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30873729
2.
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations.
Contemp Clin Trials Commun
; 30: 101000, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36186544
3.
Using Electronic Health Records to Derive Control Arms for Early Phase Single-Arm Lung Cancer Trials: Proof-of-Concept in Randomized Controlled Trials.
Clin Pharmacol Ther
; 107(2): 369-377, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350853
4.
Characterizing the Feasibility and Performance of Real-World Tumor Progression End Points and Their Association With Overall Survival in a Large Advanced Non-Small-Cell Lung Cancer Data Set.
JCO Clin Cancer Inform
; 3: 1-13, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31403818
5.
Development and Validation of a High-Quality Composite Real-World Mortality Endpoint.
Health Serv Res
; 53(6): 4460-4476, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29756355
6.
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors.
Mol Cancer Ther
; 4(6): 948-55, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15956252
7.
Response to "Externally Controlled Trials: Are We There Yet?"
Clin Pharmacol Ther
; 108(5): 920, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542772
8.
Comparing the power of the discontinuation design to that of the classic randomized design on time-to-event endpoints.
Control Clin Trials
; 25(2): 168-77, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15020035